Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

C. Lhommé · SciRah

Researcher profile · Semantic Scholar

C. Lhommé

Share profile

C. Lhommé — researcher profile on SciRah

h-index: 59
Works: 339
Citations: 11K

Most-cited papers

Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): a randomised, multicentre, double-blind, placebo-controlled phase 3 trial.
B. Monk, A. Poveda, I. Vergote, F. Raspagliesi +20 more
2014The Lancet Oncology269 citations
Semantic Scholar
Kidney Diseases Associated With Anti-Vascular Endothelial Growth Factor (VEGF)
H. Izzedine, B. Escudier, C. Lhommé, P. Pautier +8 more
2014Medicine176 citations Open access
Semantic Scholar
Neoadjuvant chemotherapy (NACT) increases immune infiltration and programmed death-ligand 1 (PD-L1) expression in epithelial ovarian cancer (EOC)
S. Mesnage, A. Auguste, C. Genestie, A. Dunant +12 more
2016Annals of Oncology155 citations Open access
Semantic Scholar
A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma Group.
P. Pautier, A. Floquet, L. Gladieff, E. Bompas +19 more
2013Annals of Oncology136 citations Open access
Semantic Scholar
Gynecologic Cancer InterGroup (GCIG) Consensus Review for Ovarian Tumors of Low Malignant Potential (Borderline Ovarian Tumors)
P. Harter, D. Gershenson, C. Lhommé, F. Lécuru +11 more
2014International Journal of Gynecologic Cancer98 citations Open access
Semantic Scholar
Guidelines for the management of ovarian cancer during pregnancy.
H. Marret, C. Lhommé, F. Lécuru, M. Canis +3 more
2010European Journal of Obstetrics, Gynecology, and Reproductive Biology91 citations
Semantic Scholar
Final results of a phase 3 study of trebananib plus weekly paclitaxel in recurrent ovarian cancer (TRINOVA-1): Long-term survival, impact of ascites, and progression-free survival-2.
B. Monk, A. Poveda, I. Vergote, F. Raspagliesi +19 more
2016Gynecologic Oncology90 citations Open access
Semantic Scholar
Prognostic factors and morbidities after completion surgery in patients undergoing initial chemoradiation therapy for locally advanced cervical cancer.
C. Touboul, C. Uzan, A. Mauguen, S. Gouy +6 more
2010The Oncologist89 citations Open access
Semantic Scholar
A randomized phase II trial of maintenance therapy with Sorafenib in front-line ovarian carcinoma.
T. Herzog, G. Scambia, Byoung-Gie Kim, C. Lhommé +7 more
2013Gynecologic Oncology85 citations
Semantic Scholar
Hyperthermic intra-peritoneal chemotherapy using oxaliplatin as consolidation therapy for advanced epithelial ovarian carcinoma. Results of a phase II prospective multicentre trial. CHIPOVAC study.
C. Pomel, Gwenael Ferron, G. Lorimier, A. Rey +8 more
2010European Journal of Surgical Oncology83 citations
Semantic Scholar
Prognostic Factors of a Large Retrospective Series of Mucinous Borderline Tumors of the Ovary (Excluding Peritoneal Pseudomyxoma)
M. Koskas, C. Uzan, S. Gouy, P. Pautier +4 more
2010Annals of Surgical Oncology78 citations
Semantic Scholar
Prognostic value of lymph node involvement in ovarian serous borderline tumors.
B. Lesieur, A. Kane, P. Duvillard, S. Gouy +4 more
2011American Journal of Obstetrics and Gynecology65 citations
Semantic Scholar
Prognostic factors in patients with ovarian serous low malignant potential (borderline) tumors with peritoneal implants.
A. Kane, C. Uzan, A. Rey, S. Gouy +6 more
2009The Oncologist64 citations
Semantic Scholar
Surgical Outcomes After Debulking Surgery for Intraabdominal Ovarian Growing Teratoma Syndrome: Analysis of 38 Cases
E. Bentivegna, H. Azaïs, C. Uzan, A. Leary +8 more
2015Annals of Surgical Oncology55 citations
Semantic Scholar
Long-term fatigue and quality of life among epithelial ovarian cancer survivors: a GINECO case/control VIVROVAIRE I study.
F. Joly, D. Ahmed-Lecheheb, E. Kalbacher, N. Heutte +26 more
2019Annals of Oncology54 citations Open access
Semantic Scholar
Impact of adjuvant treatment modalities on the management of patients with stages I-II endometrial stromal sarcoma.
G. Malouf, J. Duclos, A. Rey, P. Duvillard +6 more
2010Annals of Oncology52 citations Open access
Semantic Scholar
Prognostic factors and outcome of undifferentiated endometrial sarcoma treated by multimodal therapy
G. Malouf, C. Lhommé, P. Duvillard, P. Morice +2 more
2013International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics47 citations
Semantic Scholar
Management of cervical cancer detected during pregnancy: role of magnetic resonance imaging.
C. Balleyguier, C. Fournet, W. Ben Hassen, E. Zareski +6 more
2013Clinical imaging46 citations
Semantic Scholar
Prognostic factors in women treated for ovarian yolk sac tumour: a retrospective analysis of 84 cases.
T. de la Motte Rouge, P. Pautier, A. Rey, P. Duvillard +6 more
2011European Journal of Cancer45 citations
Semantic Scholar
Quality indicators in ovarian cancer surgery: report from the French Society of Gynecologic Oncology (Societe Francaise d'Oncologie Gynecologique, SFOG).
D. Querleu, I. Ray-Coquard, J. Classe, J. Aucouturier +17 more
2013Annals of Oncology44 citations Open access
Semantic Scholar
Phase II study of gefitinib in combination with paclitaxel (P) and carboplatin (C) as second-line therapy for ovarian, tubal or peritoneal adenocarcinoma (1839IL/0074).
P. Pautier, F. Joly, P. Kerbrat, P. Bougnoux +6 more
2010Gynecologic Oncology44 citations
Semantic Scholar
Patterns of care and outcome in elderly cervical cancer patients: a special focus on brachytherapy.
N. Magné, N. C. Mancy, E. Chajon, P. Duvillard +5 more
2009Radiotherapy and Oncology41 citations
Semantic Scholar
Impact of epidural analgesia on survival in patients undergoing complete cytoreductive surgery for ovarian cancer.
P. Capmas, V. Billard, S. Gouy, C. Lhommé +3 more
2012Anticancer Research39 citations
Semantic Scholar
Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumours: guidelines from the French national network dedicated to rare gynaecological cancers.
C. Rousset-Jablonski, F. Selle, E. Adda-Herzog, F. Planchamp +33 more
2019European Journal of Cancer34 citations Open access
Semantic Scholar
Adjuvant platinum-based chemotherapy for borderline serous ovarian tumors with invasive implants.
A. Leary, M. Petrella, P. Pautier, P. Duvillard +6 more
2014Gynecologic Oncology32 citations
Semantic Scholar
Fertility determinants after conservative surgery for mucinous borderline tumours of the ovary (excluding peritoneal pseudomyxoma).
M. Koskas, C. Uzan, S. Gouy, P. Pautier +4 more
2011Human Reproduction32 citations
Semantic Scholar
How to follow up advanced-stage borderline tumours? Mode of diagnosis of recurrence in a large series stage II-III serous borderline tumours of the ovary.
C. Uzan, A. Kane, A. Rey, S. Gouy +4 more
2011Annals of Oncology31 citations Open access
Semantic Scholar
Prognostic significance of an early decline in serum alpha-fetoprotein during chemotherapy for ovarian yolk sac tumors.
T. de la Motte Rouge, P. Pautier, C. Genestie, A. Rey +7 more
2016Gynecologic Oncology30 citations
Semantic Scholar
Sentinel Lymph Node in Endometrial Cancer: A Review
C. Touboul, E. Bentivegna, C. Uzan, S. Gouy +5 more
2013Current Oncology Reports30 citations
Semantic Scholar
Phase II of oral gimatecan in patients with recurrent epithelial ovarian, fallopian tube or peritoneal cancer, previously treated with platinum and taxanes
S. Pecorelli, I. Ray-Coquard, O. Trédan, N. Colombo +13 more
2009Annals of Oncology30 citations Open access
Semantic Scholar
Histological response is not a prognostic factor after neoadjuvant chemotherapy in advanced-stage ovarian cancer with no residual disease.
J. Ferron, C. Uzan, A. Rey, S. Gouy +4 more
2009European Journal of Obstetrics, Gynecology, and Reproductive Biology26 citations
Semantic Scholar
Phase I study of onapristone, a type I antiprogestin, in female patients with previously treated recurrent or metastatic progesterone receptor-expressing cancers
P. Cottu, J. Bonneterre, A. Varga, M. Campone +16 more
2018PLoS ONE24 citations Open access
Semantic Scholar
Prognosis and prognostic factors of the micropapillary pattern in patients treated for stage II and III serous borderline tumors of the ovary.
C. Uzan, A. Kane, A. Rey, S. Gouy +6 more
2011The Oncologist24 citations Open access
Semantic Scholar
[Initial management of gynecologic cancers: reference guides of the Société Française d'Oncologie Gynécologique (SFOG) ].
D. Querleu, P. Bonnier, P. Morice, F. Narducci +18 more
2008Gynécologie Obstétrique & Fertilité24 citations
Semantic Scholar
The PI3K/Akt/mTOR Pathway in Ovarian Cancer: Biological Rationale and Therapeutic Opportunities
A. Leary, É. Auclin, P. Pautier, C. Lhommé
201321 citations Open access
Semantic Scholar
Lymphocele and ovarian cancer: risk factors and impact on survival.
T. Gauthier, C. Uzan, D. Lefeuvre, A. Kane +6 more
2012The Oncologist21 citations Open access
Semantic Scholar
Anti-angiopoietin therapy with trebananib for recurrent ovarian cancer (TRINOVA-1): A randomised, multicentre, double-blind, placebo-controlled phase 3 trial
B. Monk, A. Poveda, I. Vergote, F. Raspagliesi +20 more
201420 citations
Semantic Scholar
Actinomycin D, cisplatin, and etoposide regimen is associated with almost universal cure in patients with high-risk gestational trophoblastic neoplasia.
C. Even, Patricia Pautier, P. Duvillard, A. Floquet +11 more
2014European Journal of Cancer18 citations
Semantic Scholar
Results of oxaliplatin-based hyperthermic intraperitoneal chemotherapy in recurrent ovarian granulosa cell tumors.
S. Gouy, C. Uzan, P. Pautier, C. Lhommé +2 more
2013European Journal of Obstetrics, Gynecology, and Reproductive Biology18 citations
Semantic Scholar
Gynecologic bleeding revealing vaginal metastasis of renal cell carcinoma
Z. Benbrahim, Ali Chouaib, R. Mazeron, M. Léger-Ravet +4 more
2013The Pan African Medical Journal15 citations Open access
Semantic Scholar
Impact of trebananib plus weekly paclitaxel on overall survival (OS) in patients (pts) with recurrent ovarian cancer and ascites: Results from the phase III TRINOVA-1 study.
B. Monk, A. Poveda, I. Vergote, F. Raspagliesi +15 more
201513 citations
Semantic Scholar
[The molecular biology of epithelial ovarian cancer].
A. Leary, P. Pautier, Y. Tazi, P. Morice +6 more
2012Bulletin du Cancer12 citations
Semantic Scholar
Results from a randomized phase II study to evaluate the safety and efficacy of acetyl-L-carnitine in the prevention of sagopilone-induced peripheral neuropathy (REASON).
C. Lhommé, D. Berton-Rigaud, F. Joly, J. Baurain +4 more
2011Journal of Clinical Oncology12 citations
Semantic Scholar
Impact of primary para-aortic lymphadenectomy on distant failure in locally advanced cervical cancer patients treated in the era of image-guided adaptive brachytherapy
Cyrus Chargari, R. Mazeron, A. Dunant, S. Gouy +13 more
2016Clinical and Experimental Metastasis10 citations
Semantic Scholar
Prognostic factors of patients with advanced stage serous borderline tumors of the ovary.
P. Morice, C. Uzan, A. Kane, A. Rey +6 more
2009Journal of Clinical Oncology10 citations
Semantic Scholar
[Fertility preservation, contraception and menopause hormone therapy in women treated for rare ovarian tumors: Guidelines from the French national network dedicated to rare gynaecological cancer].
C. Rousset-Jablonski, F. Selle, E. Adda-Herzog, F. Planchamp +32 more
2018Bulletin du Cancer9 citations Open access
Semantic Scholar
[Uterine leiomyosarcoma: epidemiology, pathology, biology, diagnosis, prognosis and treatment].
J. Hadoux, P. Morice, C. Lhommé, P. Duvillard +9 more
2013Bulletin du Cancer9 citations
Semantic Scholar
Optimizing Local Control in High-Grade Uterine Sarcoma: Adjuvant Vaginal Vault Brachytherapy as Part of a Multimodal Treatment.
P. Annède, S. Gouy, R. Mazeron, E. Bentivegna +11 more
2017The Oncologist8 citations Open access
Semantic Scholar
Safety of bevacizumab in clinical practice for recurrent ovarian cancer: A retrospective cohort study.
F. Selle, G. Emile, P. Pautier, Irène Asmane +15 more
2016Oncology Letters8 citations Open access
Semantic Scholar
Correlation Between Macroscopic and Microscopic Diseases on Splenectomies Performed in the Surgical Management of Ovarian Cancer
C. Uzan, L. Bontoux, S. Gouy, P. Duvillard +3 more
2010International Journal of Gynecologic Cancer8 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

P. Pautier×34
Invite
P. Pautier — researcher profile on SciRah
P. Morice×32
Invite
P. Morice — researcher profile on SciRah
S. Gouy×26
Invite
S. Gouy — researcher profile on SciRah
P. Duvillard×22
Invite
P. Duvillard — researcher profile on SciRah

×20

Invite

C. Uzan — researcher profile on SciRah

C. Haie-meder×15

Invite

C. Haie-meder — researcher profile on SciRah

Invite

A. Rey — researcher profile on SciRah

I. Ray-Coquard×10

Invite

I. Ray-Coquard — researcher profile on SciRah

Invite

A. Leary — researcher profile on SciRah

Invite

C. Genestie — researcher profile on SciRah

E. Bentivegna×7

Invite

E. Bentivegna — researcher profile on SciRah

Invite

A. Floquet — researcher profile on SciRah